Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

›

MYC positive	Diffuse Large B Cell Lymphoma	MYC positive	Diffuse Large B Cell Lymphoma	tisagenlecleucel-T Sensitive: C3 – Early Trials tisagenlecleucel-T Sensitive : C3	tisagenlecleucel-T Sensitive: C3 – Early Trials tisagenlecleucel-T Sensitive : C3
MYC positive	Non-Hodgkin’s Lymphoma	MYC positive	Non-Hodgkin’s Lymphoma	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3
MYC positive	Diffuse Large B Cell Lymphoma	MYC positive	Diffuse Large B Cell Lymphoma	pixantrone Sensitive: C3 – Early Trials pixantrone Sensitive : C3	pixantrone Sensitive: C3 – Early Trials pixantrone Sensitive : C3